I read with great interest Drs. Robba and Citerio’s [1] approach to intracranial pressure (ICP)-cerebral perfusion pressure (CPP) management, and it is to be commended. My approach over the years has evolved to teach a visual pyramidal approach to our nurses, residents, fellows, and now our advanced practice providers and neurosurgeons. Rather than use the Tier 0, 1, 2, 3 system as proposed by the Neurocritical Care Society in Emergency Neurologic Life Support, I often simply provide this Fig. 1 to our teams to show the foundation is laid with basics of CPP (mean arterial pressure-ICP) management. This visual diagram shows that to measure CPP, an ICP monitor and basic interventions like head/neck positioning are needed. The diagram also demonstrates the importance of emphasizing the ICP-CPP zero at the tragus for standardization [2, 3]. These fundamentals cannot be overstated, especially with nurses eager to re-emphasize at bedside the goals of care of the patient. Further, beyond basic CPP management, osmotherapy comes into play, which once exhausted, moves up the pyramid to escalation therapies of refractory ICP, including barbiturates or hypothermia, and ultimately to neurosurgical decompression (“top of the pyramid” literally and figuratively). We find this Fig. 1 useful for discussion, and even management with our fellows, as well as for long-standing issues about use of mannitol versus say hypertonic saline in osmotherapy selection, etc. We find that there is an insatiable academic thirst for knowledge around this topic each year among all team members and hope this Fig. 1 provides food for thought for similar teams at other centers [4].
Pyramidal approach to ICP-CPP management. Barbs indicates barbiturates; CPP, cerebral perfusion pressure; CVC, central venous line; HOB, head of bed; HTS, hypertonic saline; ICP, intracranial pressure; IV, intravenous; MAP, mean arterial pressure; NMB, neuromuscular blockade; POsm, plasma osmolality. Used with permission of Mayo Foundation for Medical Education and Research, all rights reserved
Availability of data and materials
NA.
References
Robba C, Citerio G. How I manage intracranial hypertension. Crit Care. 2019;23:243.
Freeman WD. Management of Intracranial Pressure. Continuum (Minneap Minn). 2015;21:1299–323.
Freeman WD. Cerebral perfusion pressure versus intracranial pressure-driven therapy on outcomes. Crit Care Med. 2015;43:e29.
Lewandowski-Belfer JJ, Patel AV, Darracott RM, Jackson DA, Nordeen JD, Freeman WD. Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension. Neurocrit Care. 2014;20:436–42.
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
WDF is the sole contributor to this work, and so, contributed to every aspect. The author read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
NA.
Consent for publication
NA.
Competing interests
The author declares that he has no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1186/s13054-019-2529-z.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Freeman, W.D. How I manage ICP-CPP: a visual, yet individualized approach. Crit Care 23, 287 (2019). https://doi.org/10.1186/s13054-019-2565-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13054-019-2565-8